Posted on 23 January 2024

VIVEbiotech featured in an article in the Winter print issue of Drug Discovery World

Towards the end of last year, Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, was asked about her predictions for 2024 by the Drug Discovery World.

Natalia´s 2024 predictions have been included in the journal´s Winter print issue. The contribution can be found on pages 8-9 in the following link: https://www.ddw-online.com/ddw-winter-2023-2024-27994-202401/

Natalia predicts a very good year for the advanced therapies sector and expects the use of lentiviral vectors to continue to increase.